ACADIAN ASSET MANAGEMENT LLC - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 81 filers reported holding MEI PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of MEI PHARMA INC
ValueSharesWeighting
Q1 2023$1,088
-6.0%
4,758,3640.0%0.01%
-16.7%
Q4 2022$1,158
-99.9%
4,758,364
+49.2%
0.01%
-14.3%
Q3 2022$1,232,000
-9.1%
3,190,067
+42.3%
0.01%0.0%
Q2 2022$1,356,000
+393.1%
2,241,623
+390.6%
0.01%
+600.0%
Q1 2022$275,000
-74.7%
456,878
+16.0%
0.00%
-75.0%
Q3 2021$1,087,000
-43.0%
393,991
-41.1%
0.00%
-42.9%
Q2 2021$1,907,000
-28.3%
669,112
-13.7%
0.01%
-30.0%
Q1 2021$2,659,000
+154.0%
775,388
+95.3%
0.01%
+150.0%
Q4 2020$1,047,000
+124.7%
396,999
+165.2%
0.00%
+100.0%
Q3 2020$466,000
+689.8%
149,672
+310.1%
0.00%
Q1 2020$59,000
-82.2%
36,500
-66.2%
0.00%
-100.0%
Q1 2019$332,000
-32.5%
108,064
-42.0%
0.00%
-50.0%
Q4 2018$492,000
-26.7%
186,335
+19.8%
0.00%
-33.3%
Q3 2018$671,000
+0.3%
155,521
-8.5%
0.00%0.0%
Q2 2018$669,000
-24.6%
169,882
-60.4%
0.00%
-25.0%
Q1 2018$887,000
-13.9%
428,592
-12.7%
0.00%0.0%
Q4 2017$1,030,000
-32.5%
491,125
-13.9%
0.00%
-42.9%
Q3 2017$1,527,000
+4527.3%
570,377
+4081.3%
0.01%
Q2 2017$33,000
+57.1%
13,641
+6.1%
0.00%
Q1 2017$21,000
+162.5%
12,857
+120.8%
0.00%
Q4 2016$8,000
-52.9%
5,822
-38.7%
0.00%
Q3 2016$17,000
+21.4%
9,495
+10.2%
0.00%
Q4 2015$14,0008,6200.00%
Other shareholders
MEI PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 3,018,059$4,467,0004.40%
CAXTON CORP 885,560$1,426,0001.56%
Vivo Capital, LLC 9,784,422$15,753,0001.43%
Sio Capital Management, LLC 2,485,098$4,001,0001.34%
BVF INC/IL 5,046,272$8,124,0000.76%
NEA Management Company, LLC 8,533,072$13,738,0000.72%
Boxer Capital, LLC 2,913,091$4,690,0000.32%
Perceptive Advisors 3,030,440$4,879,0000.13%
WASATCH ADVISORS LP 5,070,718$8,164,0000.08%
KNOTT DAVID M 38,590$62,0000.04%
View complete list of MEI PHARMA INC shareholders